141 – 150 of 309
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2016
-
Mark
Chemical properties of lipids strongly affect the kinetics of the membrane-induced aggregation of α-synuclein
2016) In Proceedings of the National Academy of Sciences of the United States of America 113(26). p.7065-7070(
- Contribution to journal › Article
-
Mark
Platelet-derived growth factor-BB has neurorestorative effects and modulates the pericyte response in a partial 6-hydroxydopamine lesion mouse model of Parkinson's disease
(
- Contribution to journal › Article
-
Mark
Duration of disease does not equally influence all aspects of quality of life in Parkinson's disease
(
- Contribution to journal › Article
-
Mark
How can rAAV-α-synuclein and the fibril α-synuclein models advance our understanding of Parkinson's disease?
(
- Contribution to journal › Scientific review
-
Mark
Impulse Control Disorders : The Continuum Hypothesis
(
- Contribution to journal › Article
-
Mark
A European multicentre survey of impulse control behaviours in Parkinson's disease patients treated with short- and long-acting dopamine agonists
(
- Contribution to journal › Article
-
Mark
Continuous dopaminergic stimulation therapy for Parkinson's disease - Recent advances
(
- Contribution to journal › Article
-
Mark
Fall-related activity avoidance in relation to a history of falls or near falls, fear of falling and disease severity in people with Parkinson's disease
(
- Contribution to journal › Article
-
Mark
Dramatic differences in susceptibility to L-DOPA-induced dyskinesia between mice that are aged before or after a nigrostriatal dopamine lesion
(
- Contribution to journal › Article
-
Mark
Value of cerebrospinal fluid α-synuclein species as biomarker in Parkinson's diagnosis and prognosis
(
- Contribution to journal › Scientific review